About
A Global Dissolution Research Presentations
Competition for Young Pharmaceutical Researchers.
Follow Us
© Copyright 2023 SPDS India - All Rights Reserved
| Poster No. | Abstract title |
| P01 | A multistage dissolution strategy to mimic biorelevant conditions for different generic products of BCS class II compound with pH dependent solubility. |
| P02 | Box-Behnken guided development of an ecofriendly RP-HPLC analytical method to check the in-vitro drug release profile of pantoprazole sodium and piperine co-loaded mucoadhesive GRDDS formulation for H. pylori eradication |
| P03 | Comparative bioavailability study of Nimodipine transdermal patch and conventional oral suspension |
| P04 | Comparative in-vitro release of Risperidone loaded long acting microspheres with marketed formulation |
| P05 | Computational Modeling and Simulation of Alternative Setups for Drug Dissolution |
| P06 | Deciphering Bimodal Solubility and Dissolution Profiles in Anti-Epileptic Drug-Drug Cocrystals: A Combined Experimental-Computational Approach with Chemometrics |
| P07 | Design and Evaluation of a Topical Fast-penetrating Solution for Gout Therapy: In vitro, Ex vivo, and In vivo Assessment |
| P08 | Design and Optimization of Andrographolide and Mahua oil loaded Emulgels for Enhanced Skin Permeability and Skin Cancer Treatment |
| P09 | Designing, Sintering and Profiling of fixed-dose anti-tuberculosis drugs loaded 3D printlets using selective laser sintering (SLS) additive manufacturing technology |
| P10 | Developing and optimizing the enhanced ocular delivery of Dexamethasone through Glycerosomes laden contact lens |
| P11 | Dissolution and Bioavailability Enhancement of Abiraterone Acetate Solid Dispersion by Hot Melt Extrusion using HPMC HME: An Industry Feasible and Scalable Technique |
| P12 | Dissolution Assisted Interpretation of High Efficacy of ATIS-ARM-LUM - Long Acting Intramuscular Injection |
| P13 | Drug Loading Influences Amorphous-Amorphous Phase Separation (AAPS)-mediated nanodroplet formation during dissolution of Amorphous Solid Dispersions (ASDs) |
| P14 | Enhanced Permeation of Anti-EGFR Drug Using Mesoporous Silica Nanoparticle-Based Gel for Precancerous oral lesions |
| P15 | Enhanced Therapeutic Efficacy of BCS class II drug via Nanostructured Lipid Carriers Loaded Gel for Arthritis Treatment |
| P16 | Enhancing Oral Bioavailability of a Bioactive Alkaloid for Alzheimer Disease treatment using Self-Micellizing Solid Dispersion Strategy |
| P17 | Enhancing Topical Permeability of A Potent Immunosuppressant via Lipidic Nanosystems For Effective Management of Rheumatoid Arthritis |
| P18 | Evaluating the efficiency of biphasic media to characterize the dissolution profile of albumin-based injectable nanoparticle. |
| P19 | Exploring High Permeation Vesicles-Mediated Transdermal Delivery of Methotrexate for Rheumatoid Arthritis Treatment |
| P20 | Exploring Novel In-vitro Drug Release Testing Assembly for Medicated Chewing Gum |
| P21 | Exploring the polymer-excipient amalgamation in supersaturable Loratadine ternary amorphous solid dispersion for enhanced in-vitro and in-vivo performance |
| P22 | Implementation of convolution method of IVIVC for predicting in-vivo drug plasma concentration using in-vitro dissolution data. |
| P23 | Improvement of Drug Release from Colloidal Silicon Dioxide incorporated Empagliflozin Ocular Insert: monitoring of IOP and IVIVC |
| P24 | In vitro development and characterization of Herbal drug based Nano emulsion for management of Eczema |
| P25 | Innovative Insights into Nanoparticle Drug Release: Comparative Analysis of Dialysis Bag and Flow Through Cell Apparatus |
| P26 | In-Vitro Drug Release Behaviour of Cyclodextrin Complexed Anti VEGF Agent Based Nanofiber Mat as Locoregional Therapy for Oral Cancer |
| P27 | Invitro evaluation of mannosylated Curcumin liposome |
| P28 | In-vitro/in-vivo evaluation of an optimized fast-dissolving drug-nutraceutical co-amorphous dispersion presents an opportunity for enhancing drug product efficacy |
| P29 | Ionic Liquid-Based Ionogel for Transdermal Delivery of Etodolac for the Treatment of Rheumatoid Arthritis |
| P30 | Liposomal hydrogels as vesicular carriers for the delivery of Stavudine to treat retroviral infections |
| P31 | Methodological Approaches in Permeability Study of BCS Class IV Drug |
| P32 | Modulating Dissolution and Permeability of Acetazolamide through Cocrystallization: Insights from Molecular Dynamics |
| P33 | Molecular Docking based Dissolution Method Development of Delamanid |
| P34 | Mucoadhesive transnasal Paliperidone nanoemulsions for improved brain delivery – in vitro and in vivo studies |
| P35 | QbD-Driven Development of Sublingual Alfuzosin for Improved BPH Therapy |
| P36 | Self-micro emulsifying drug delivery system for Enhancement of dissolution of Efonidipine hydrochloride ethanolate |
| P37 | Solubility Enhancement of BCS class II drug: A Comparative Study of Novel Approaches |
| P38 | Solubility enhancement of Fimasartan through in-silico guided crystal engineering |
| P39 | Through the lens of innovation: developing and optimizing microemulsion-embedded contact lenses for controlled ocular drug delivery |
| P40 | Impact of Tableting Excipients on Dissolution of Amorphous Solid Dispersion during Compaction |
| P41 | Improving Dissolution of BCS Class IV Drug using Nano-suspension Approach |
| Sr | Abstract Title |
| M01 | Amorphous Solid Dispersions of Niclosamide with various grades of polyethylene glycol: Characterization by Microscopic Image Analysis and In vitro Dissolution |
| M02 | Artificial in-vitro Blood-Brain Barrier (BBB) model for preclinical screening |
| M03 | Comparative Study of Mesoporous Silica Nanoparticles |
| M04 | Development & Evaluation of Anti-cancer Formulation |
| M05 | Development & evaluation of topical quercetin loaded bilosomal gel formulation for psoriasis |
| M06 | Development and Evaluation of Diclofenac loaded self micro emulsifying drug delivery system |
| M07 | Development and In-Vitro colonic release of Formononetin-loaded Nanostructured Lipid Carriers |
| M08 | Development of curcumin-loaded functionalized MWCNT as a delivery system for the management of Alzheimer’s disease. |
| M09 | Development of dissolution method for Oro-dispersible films containing Bilastine and Montelukast Sodium |
| M10 | Development of fatty acid based microemulgel loaded with tofacitinib for the treatment of atopic dermatitis |
| M11 | Dissolution Enhancement of Nevirapine Using Solid Dispersion Approach |
| M12 | Dissolution method development for povidone iodine vaginal pessaries |
| M13 | Dissolution Testing and PBPK modelling as a tool for the development of generic telmisartan formulation |
| M14 | Effect of Infill Variables on Dissolution of 3D Printed Tablets |
| M15 | Enhanced ocular delivery of Vitamin A palmitate in management of dry eye disease. |
| M16 | Enhancing the Oral Bioavailability of Rosuvastatin Calcium through Inclusion Complexation with 2-Hydroxypropyl-beta-Cyclodextrin: An Early Stage Investigation |
| M17 | Evaluation of Erlotinib ionogel as a non-invasive yet localized breast cancer therapy |
| M18 | Evaluation of release of BCS class II drug from liquid-filled hard gelatin capsule |
| M19 | Exploration of conventional and FDM-mediated 3D printed tablets fabricated using HME based filaments for pH dependent drug delivery |
| M20 | Exploring the Potential of Nanosuspensions in Enhancing the Dissolution Profile and Oral Bioavailability of Gefitinib |
| M21 | Exploring the Potential of Polymeric Micellar Gel for Enhancing the Efficacy of Adapalene and Benzoyl Peroxide for the Treatment of Acne |
| M22 | Formulation and evaluation of flurbiprofen loaded oleogel for ocular delivery |
| M23 | Formulation and characterization of Fluocinolone acetonide loaded microneedles for posterior uveitis. |
| M24 | Formulation and characterization of pirfenidone loaded nanostructured lipid carrier based in situ gel for corneal wound healing |
| M25 | Formulation and Evaluation of Nanoemulsion-Based In-Situ Gel for Enhanced Ocular Drug Delivery System |
| M26 | Formulation and evaluation of rutin loaded bilosomes for its antioxidant activity |
| M27 | Formulation and Optimization Of Thermosensitive Parenteral In-situ Gel For Combined Effect Of Diacerein And Diclofenac |
| M28 | Formulation Development and Characterization of Solid Dispersion Loaded Vaginal Sponge |
| M29 | Formulation development and efficacy study of nanoparticles for nose to brain delivery |
| M30 | Formulation Development, Optimization And Characterization Of pH Sensitive Oral Floating In-situ Gel Of Metronidazole In Combination With Ofloxacin For Paediatric Use |
| M31 | Impact of CD complexation on solubility & dissolution of Epalrestat |
| M32 | Improve Solubility and Permeability of Donepezil by Nanostructured Lipid Carrier System for Nose to Brain Delivery |
| M33 | In vitro Release testing (IVRT) method development of Ganciclovir nanocarrier based in situ ophthalmic gel using USP Apparatus Type IV |
| M34 | Inhalable dry powder formulation of voriconazole loaded transferosomes for the treatment of invasive pulmonary aspergillosis |
| M35 | Investigating the Potential of Nanostructured Lipid Carriers in Oral Bioavailability Enhancement of Venetoclax |
| M36 | Investigation on solubility enhancement of Relugolix by solid dispersion techniques |
| M37 | LC-MS/MS Analysis - A Sensitive and Specific Bioanalytical Tool for IVPT Studies by Partial Media Replacement Method - Case Study with 5%w/w Acyclovir Cream |
| M38 | Long Acting Aqua Triggered In situ gelling Meloxicam Injection |
| M39 | Modified 3D printed dissolution cell of USP type-4 apparatus: Novel approach for accelerated dissolution testing of In-situ gel formulations. |
| M40 | Novel Taste Masked ODTs of Metronidazole for Amoebiasis Treatment in Paediatrics |
| M41 | Novel topical formulation for management of melasma: improving in-vitro safety and efficacy |
| M42 | Novel Transdermal Delivery of Ofloxacin for Sustained Effect. |
| M43 | Polymer Latex based Pickering Emulsion for Topical Therapy of Psoriasis: In vitro and In vivo Evaluation. |
| M44 | Preparation and Characterization of Electrospun Dexamethasone sodium phosphate nanofiber for the treatment of Dry Eye Disease |
| M45 | Silymarin loaded multi-walled carbon nanotubes for treatment of hepatic cancer. |
| M46 | Small Sample Dissolution Studies: A Promising tool to Compare Taste-masking of Primaquine Phosphate |
| M47 | Solubility enhancement of Amphotericin-B by design of Amphotericin B ϒ-Cyclodextrin binary complex and ternary complexes using water-soluble polymers |
| M48 | The tunable dissolution profile of tinidazole from 3D printed sintered tablets using ideal composites & novel IR dye |
A Global Dissolution Research Presentations
Competition for Young Pharmaceutical Researchers.
© Copyright 2023 SPDS India - All Rights Reserved